The Pediatric Rheumatology Tissue Repository (PRTR) has been a funded component of a P30 Rheumatic Disease Core Center since 2001 and a major contributor to the past success of the P01 program. This core assists local and national investigators in specimen collection, processing, storage and distribution of biospecimens for rheumatic diseases-related studies. Because of the continued sample collection needs and special concerns in processing for the proposed P01 program, we are proposing to continue to fund a supplement to PRTR. The purpose of the supplement will be to expand the collection of patient and control samples to meet the needs of the 4 P01 projects. The scope of specimens needed for the P01 projects is extensive and can only be accomplished through collaborative efforts with additional clinical investigative sites (managed through the Admin Core). These new P01 collections will include blood (PAXgene tubes) DNA, serum, peripheral blood mononuclear cells, synovial fluid mononuclear cells and sorted cell subsets. RNA will be made from PAXgene samples, mononuclear cells and sorted cell populations. The tissue core will ensure uniform collection locally and nationally which is imperative due to the sensitivity of gene expression measurements. The tissue core will handle samples in a manner to protect patient confidentiality and to meet IRB requirements. Once collected, the tissue repository will be responsible for the distribution of samples to the individual projects or alternatively, the tissue repository will submit the samples directly to the Affymetrix core or the flow cytometry core for analysis. Established practices of the PRTR for sample collection, processing shipping and training of clinical site personnel ensure that the scope of specimens needed for the P01 research projects which are necessary to understand and define childhood rheumatic diseases are available.

Public Health Relevance

The Tissue Core of the Program Project will collect, process, store and distribute biological specimens that include blood, DNA, serum, isolated blood cells, isolated synovial fluid cells, synovial fluid, and RNA. These centralized operations will ensure uniformity, efficiency and quality that will foster the success of each of the four projects in this Program Project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Program Projects (P01)
Project #
5P01AR048929-09
Application #
8727965
Study Section
Special Emphasis Panel (ZAR1-HL)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
9
Fiscal Year
2014
Total Cost
$71,051
Indirect Cost
$35,865
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Morris, D L; Fernando, M M A; Taylor, K E et al. (2014) MHC associations with clinical and autoantibody manifestations in European SLE. Genes Immun 15:210-7
Schulert, Grant S; Grom, Alexei A (2014) Macrophage activation syndrome and cytokine-directed therapies. Best Pract Res Clin Rheumatol 28:277-92
Moncrieffe, Halima; Prahalad, Sampath; Thompson, Susan D (2014) Genetics of juvenile idiopathic arthritis: new tools bring new approaches. Curr Opin Rheumatol 26:579-84
Hinks, Anne; Martin, Paul; Thompson, Susan D et al. (2013) Autoinflammatory gene polymorphisms and susceptibility to UK juvenile idiopathic arthritis. Pediatr Rheumatol Online J 11:14
Gorelik, Mark; Fall, Ndate; Altaye, Mekibib et al. (2013) Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 40:1191-9
Hinks, Anne; Cobb, Joanna; Sudman, Marc et al. (2012) Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap. Ann Rheum Dis 71:1117-21
Ercan, Altan; Barnes, Michael G; Hazen, Melissa et al. (2012) Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation. Arthritis Rheum 64:3025-33
Hinze, Claas H; Fall, Ndate; Thornton, Sherry et al. (2010) Immature cell populations and an erythropoiesis gene-expression signature in systemic juvenile idiopathic arthritis: implications for pathogenesis. Arthritis Res Ther 12:R123
Thompson, Susan D; Sudman, Marc; Ramos, Paula S et al. (2010) The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1. Arthritis Rheum 62:3265-76
Barnes, Michael G; Grom, Alexei A; Thompson, Susan D et al. (2010) Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis. Arthritis Rheum 62:3249-58

Showing the most recent 10 out of 26 publications